Full text is available at the source.
Abstract
A detection limit of 0.284 nM for kanamycin was achieved using a novel biosensor.
- The biosensor utilizes a CRISPR-Cas12a signal amplification mechanism for enhanced sensitivity.
- A ZnO/CdS heterojunction photoanode increases photocurrent production by 96% compared to ZnO alone.
- The sensor demonstrates a linear response range from 10 to 1000 nM for kanamycin detection.
- Cross-reactivity with related compounds is less than 2.8%.
- Average recovery rates in spiked milk samples are 97%, with a relative standard deviation of 2.2%.
Simplified